Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Interim Management Statement

16 Nov 2009 07:00

RNS Number : 5279C
Persimmon PLC
16 November 2009
 



INTERIM MANAGEMENT STATEMENT

16 NOVEMBER 2009

Persimmon plc today releases its third quarter Interim Management Statement which covers the period from 1 July 2009 to 16 November 2009.

Since we announced our Half Year Results on 25 August 2009 trading activity levels have continued ahead of last year. We expect to legally complete c. 9,000 homes for the year ending 31 December 2009.

Sales volumes over recent weeks have continued to be satisfactory with the encouraging rate of sales achieved through the summer months being maintained during the autumn period. Prices have also held firm. Forward sales are now well ahead of last year and we expect to carry forward a healthy order book into 2010. We are currently fully sold up for 2009 and have a further c. £500 million of sales already taken for 2010 which is c. 50% ahead of the same point last year.

Continued good visitor levels, low cancellation rates of c. 16% and the increase of c. 6% in the average selling price of homes reserved since 1 July 2009 to c. £173,000 provides a more positive position. The improvement in average selling price is largely the result of a change in sales mix, but also reflects some modest price growth in some regional markets. We have sold a greater proportion of private houses and fewer apartments in the period, whilst Housing Association sales volumes have been lower. We are focusing on margin enhancement wherever possible.

Whilst we are increasing investment in new site openings and some selective land purchases, close control of cash generation continues. Debt continues to reduce, notwithstanding the increased investment in work in progress for year end legal completions and a further 50 new site openings in the second half of 2009 for completions in 2010. At 31 October 2009 total borrowings were £399 million (31 October 2008: £960 million). October is usually a peak debt month and therefore we expect borrowings at the year end to be significantly lower than the £400 million guidance we gave at the announcement of our Half Year Results, which itself was an improvement from previous guidance.

This puts us in a very strong position to continue to open new outlets and purchase new land as and when it becomes available. In the second half we have agreed terms to buy c. 2,850 plots on 34 new sites, including c. 350 plots from our strategic landbank. Most of these additional plots are located in the south of England. We currently have c. 62,500 plots of land owned and under control.

Whilst sales volumes have been consistent, we still have significant concerns regarding the availability of mortgages, particularly the higher loan to value products required by first time buyers. However, we have been pleased with the customer interest in the Government HomeBuy Direct Scheme. We have worked hard to maximise these sales on numerous sites across the UK and recently the 1,000th Persimmon home was reserved with this scheme since its launch in March this year.

In summary, whilst we remain concerned about the potential impact on our markets of any significant increase in unemployment over the coming months, debt is reducing well ahead of our previous guidance, sales volumes have stabilised and pricing conditions are currently more positive. Having strengthened our forward order book and reduced borrowings significantly, the Group's financial position remains strong.

We will give a further update on progress and trading following the year end on Thursday 7 January 2010. 

For further information, please contact:

Edward Orlebar

Charlotte McMullen

Marylène Guernier

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

Persimmon plc

M:Communications

Tel: +44 (0) 1904 642199

Tel: +44 (0) 20 7920 2333


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUOSBRKARAAAA
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.